Navigation Links
Pharsight Signs New Diabetes Meta-Database Customer
Date:3/27/2008

Top 20 Global Pharmaceutical Company Licenses Public-Source Database to Quantify Competitive Treatment Landscape and Support Model-Based Drug

Development

MOUNTAIN VIEW, Calif., March 27 /PRNewswire-FirstCall/ -- Pharsight Corporation (Nasdaq: PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that it has licensed its public-source Type II Diabetes meta- database to a Top 20 global pharmaceutical company. The customer expects to use the database to build quantitative models of the competitive landscape for oral diabetes treatments that will support clinical program decision-making for promising compounds in its diabetes pipeline. This is the second license Pharsight has sold for its diabetes meta-database.

Pharsight's meta-database for Type II Non-Insulin Dependent Diabetes Mellitus (NIDDM) captures clinical efficacy and safety measures from 106 clinical trials, including multiple drug classes and comparative treatments and more than 30 clinical endpoints.

Pharsight has assembled a team of clinical database and clinical pharmacy experts dedicated to extracting information from the public domain and transforming this information into model-ready datasets. These datasets are used by biopharmaceutical companies and Pharsight scientific consultants to answer a variety of drug development questions. Pharsight offers public-source meta-databases in nine therapeutic areas, covering 20 disease indications. Additional information is available at http://www.pharsight.com/services/scs_sub_metadata.php.

"Pharsight is pleased that another leading pharmaceutical company has elected to use our meta-database to enable objective comparisons of drug effects for its diabetes programs," said Shawn O'Connor, president, chief executive officer and chairman of Pharsight. "Using public domain data extracted from the scientific literature to build predictive models of the competitive landscape provides a quantitative means for understanding the clinical potential of a drug candidate and earlier assessment of its' competitive viability. Pharsight systematically compiles public-source clinical databases, many in high-prevalence disease areas, with a deliberate focus to enable knowledge sharing and efficient drug-disease modeling to support our client's critical drug development decisions."

About Pharsight Public-Source Meta-databases

Pharsight meta-databases provide highly structured quantitative information from the public-source scientific literature that can be used to understand the competitive landscape for a particular therapeutic area and indication. Meta-databases provide a starting point for model-based drug development approaches, and when combined with proprietary data on specific compound(s) can be used to manage risk and address specific drug development program questions concerning dose selection, efficient and effective trial design, and "go/no-go" decisions. Pharsight offers meta-databases in nine therapeutic areas, covering 20 disease indications that include type II diabetes, thrombosis, depression and insomnia.

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. The company's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com.

Forward Looking Statements

The statements in this press release related to the design and performance of the Pharsight public-source meta-database offering are forward looking statements. Forward-looking statements are inherently speculative, and actual results may differ materially from Pharsight's expectations due to a variety of factors, including: changes in FDA regulations may affect the demand for the product; and customers may not perceive the benefits of the product to be the same as Pharsight believes them to be. Other risk factors relating to Pharsight are disclosed in the company's most recent Form 10-Q filed with the Securities and Exchange Commission on February 14, 2008. All forward-looking statements are based on information available to the company on the date hereof, and the company assumes no obligation to update such statements.

Registered Trademarks and Trademarks

Pharsight is a registered trademark of Pharsight Corporation. All other brand and product names are trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE Pharsight Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pharsight to Present at eClinical Forum
2. Pharsight to Host Webinar on Hepatitis C Virus (HCV) and HIV Drug-Disease Modeling
3. FDA and Pharsight Continue to Collaborate Under CRADA
4. Pharsight to Present at DIA Cardiac Safety Conference on December 4, 2007
5. Pharsight Achieves $7.3 Million in Quarterly Revenue
6. Pharsight Expands Global Consulting Services Teams
7. Pharsight to Host European Software Conference
8. Pharsight Files Application for Nasdaq Capital Market Listing
9. Governor Strickland Signs House Bill 125 Into Law
10. Know Suicides Warning Signs
11. Godfather of Physical Fitness, Jack LaLanne, Signs Newest Book at Borders Penn Plaza Friday, March 21st from 5:30 PM to 7:30 PM ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a ... utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the ... a CBD form that can be easily incorporated into liquid products, while reducing costs ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & ... and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to ... with elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded ...
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
Breaking Medicine Technology: